Nonadherence to semaglutide for obesity worsened once out-of-pocket costs passed roughly $75 per 30-day supply among commercially insured adults.
Related to this article
Karen van Caulil, PhD, on how employers can improve cancer care by investing in access, prevention, and support through treatment and survivorship.
Debra Patt, MD, PhD, MBA, MPH, discusses AI adoption, administrative burden, and strategies to streamline prior authorization in oncology.
Trending on AJMC
1
Contributor: Congress Can Bring Mental Health Care to the 21st Century
2
Lung Cancer Progress Drives Down US Cancer Death Rates
3
Panel to Detail Community Oncology Survey on Gaps Between Innovation and Implementation in Cancer Care
4
Oncology Patients in Clinical Trials: A Health Care Cost Analysis
5